Disc Medicine (IRON) Operating Expenses (2020 - 2026)

On a trailing twelve-month basis, Disc Medicine's Operating Expenses was $269.27 million through Jun 30, 2026, up 59.6% year-over-year; for FY2025, it was $236.02 million, up 81.9% from FY2024.

• Operating Expenses has now increased for four consecutive years, with a five-year compound annual growth rate of 47.3% (FY2020 to FY2025).
• In earlier years, Operating Expenses was $129.72 million in FY2024 (+42.4%), $91.13 million in FY2023 (+91.9%), $47.48 million in FY2022 (+53.5%) and $30.93 million in FY2021 (-9.1%).
• Quarterly Operating Expenses has moved between -$20.33 million (Q4 2021) and $69.52 million (Q1 2026) over five years.
• Compared with a year earlier, Operating Expenses has increased for 14 straight quarters, with growth averaging 61.9% over the last eight quarters.
• The best year-over-year quarter for Operating Expenses over five years was Q1 2023 (growth of 152.3%); the worst was Q3 2022 (a decline of 43.2%).
• Per Business Quant data, IRON's Operating Expenses in the three quarters before Q2 2026 was $69.52 million (Q1 2026), $66.97 million (Q4 2025) and $67.7 million (Q3 2025).